These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15102601)

  • 1. Use of suicide genes for cancer gene therapy: study of the different approaches.
    Vassaux G; Martin-Duque P
    Expert Opin Biol Ther; 2004 Apr; 4(4):519-30. PubMed ID: 15102601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging fields of suicide gene therapy and virotherapy.
    Kirn D; Niculescu-Duvaz I; Hallden G; Springer CJ
    Trends Mol Med; 2002; 8(4 Suppl):S68-73. PubMed ID: 11927291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary study on the construction of double suicide gene delivery vectors by mesenchymal stem cells and the in vitro inhibitory effects on SKOV3 cells.
    Jiang J; Wei D; Sun L; Wang Y; Wu X; Li Y; Fang Z; Shang H; Wei Z
    Oncol Rep; 2014 Feb; 31(2):781-7. PubMed ID: 24317390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Origins of Suicide Gene Therapy.
    Düzgüneş N
    Methods Mol Biol; 2019; 1895():1-9. PubMed ID: 30539525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the bystander effect in suicide gene therapy.
    Pope IM; Poston GJ; Kinsella AR
    Eur J Cancer; 1997 Jun; 33(7):1005-16. PubMed ID: 9376180
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene therapy in human cancer: report of human clinical trials.
    Wasil T; Buchbinder A
    Cancer Invest; 2000; 18(8):740-6. PubMed ID: 11107444
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteonectin Promoter-Mediated Suicide Gene Therapy of Prostate Cancer.
    Hsiao WC; Sung SY; Chung LWK; Hsieh CL
    Methods Mol Biol; 2019; 1895():27-42. PubMed ID: 30539527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of prodrugs for suicide gene therapy.
    Niculescu-Duvaz D; Niculescu-Duvaz I; Springer CJ
    Methods Mol Med; 2004; 90():161-202. PubMed ID: 14657564
    [No Abstract]   [Full Text] [Related]  

  • 10. Suicide gene therapy in cancer: where do we stand now?
    Duarte S; Carle G; Faneca H; de Lima MC; Pierrefite-Carle V
    Cancer Lett; 2012 Nov; 324(2):160-70. PubMed ID: 22634584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
    Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
    Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to suicide gene therapy.
    Kuriyama S; Tsujinoue H; Yoshiji H
    Methods Mol Med; 2004; 90():353-69. PubMed ID: 14657573
    [No Abstract]   [Full Text] [Related]  

  • 14. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
    Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
    Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral HSV-Tk.007-mediated suicide gene therapy is not toxic for normal brain cells.
    Hossain JA; Ystaas LR; Mrdalj J; Välk K; Riecken K; Fehse B; Bjerkvig R; Grønli J; Miletic H
    J Gene Med; 2016 Sep; 18(9):234-43. PubMed ID: 27490042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring HSV-TK/ganciclovir cancer suicide gene therapy using CdTe/CdS core/shell quantum dots.
    Shao D; Zeng Q; Fan Z; Li J; Zhang M; Zhang Y; Li O; Chen L; Kong X; Zhang H
    Biomaterials; 2012 Jun; 33(17):4336-44. PubMed ID: 22440046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene therapy for hepatocellular carcinoma].
    Ohashi M; Kanai F; Shiratori Y; Omata M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():699-704. PubMed ID: 11762040
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in imaging gene-directed enzyme prodrug therapy.
    Bhaumik S
    Curr Pharm Biotechnol; 2011 Apr; 12(4):497-507. PubMed ID: 21342105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and immunologic effects of in vivo retrovirus-mediated gene transfer of the herpes simplex-thymidine kinase gene into solid tumors.
    Culver KW; Moorman DW; Muldoon RR; Paulsen RM; Lamsam JL; Walling HW; Link CJ
    Cold Spring Harb Symp Quant Biol; 1994; 59():685-90. PubMed ID: 7587131
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of prostate cancer by suicide gene targeting the FCY1 and HSV-TK genes.
    Yue QH; Hu XB; Yin Y; Su MQ; Cheng XD; Yang L; Zhou TC; Hao X
    Oncol Rep; 2009 Dec; 22(6):1341-7. PubMed ID: 19885585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.